- Home
- IMRN vs SEED Comparison
IMRN vs SEED Comparison
Compare IMRN & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- SEED
- Stock Information
- Founded
- IMRN 1994
- SEED 1997
- Country
- IMRN Australia
- SEED China
- Employees
- IMRN N/A
- SEED N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- SEED Farming/Seeds/Milling
- Sector
- IMRN Health Care
- SEED Consumer Staples
- Exchange
- IMRN Nasdaq
- SEED Nasdaq
- Market Cap
- IMRN 10.1M
- SEED 16.1M
- IPO Year
- IMRN N/A
- SEED N/A
- Fundamental
- Price
- IMRN $1.80
- SEED $1.86
- Analyst Decision
- IMRN Strong Buy
- SEED
- Analyst Count
- IMRN 1
- SEED 0
- Target Price
- IMRN $5.00
- SEED N/A
- AVG Volume (30 Days)
- IMRN 3.2K
- SEED 28.7K
- Earning Date
- IMRN 03-25-2025
- SEED 02-10-2025
- Dividend Yield
- IMRN N/A
- SEED N/A
- EPS Growth
- IMRN N/A
- SEED N/A
- EPS
- IMRN N/A
- SEED 0.46
- Revenue
- IMRN $4,048,286.00
- SEED $16,163,803.00
- Revenue This Year
- IMRN N/A
- SEED N/A
- Revenue Next Year
- IMRN N/A
- SEED N/A
- P/E Ratio
- IMRN N/A
- SEED $4.14
- Revenue Growth
- IMRN 82.90
- SEED 21.51
- 52 Week Low
- IMRN $1.70
- SEED $1.64
- 52 Week High
- IMRN $3.09
- SEED $6.38
- Technical
- Relative Strength Index (RSI)
- IMRN 45.49
- SEED 45.22
- Support Level
- IMRN $1.75
- SEED $1.86
- Resistance Level
- IMRN $2.07
- SEED $1.98
- Average True Range (ATR)
- IMRN 0.11
- SEED 0.12
- MACD
- IMRN -0.01
- SEED -0.01
- Stochastic Oscillator
- IMRN 33.61
- SEED 27.25
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company. In crop seed biotechnologies, the company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.